Retatrutide (developmental code: LY3437943) is an investigational synthetic peptide developed by Eli Lilly and Company
From a pure pharmacological standpoint, these medications work on entirely different systems through entirely different mechanisms
And in a field as personal as weight management, nuance matters
It has a low downtime and is not invasive
Along with a couple of other ingredients, these two wonder actives work in tandem to stimulate collagen, smooth uneven pigmentation and even promote healing
Everything we prescribe comes from regulated US peptide manufacturers and distributors with a certificate of analysis on every batch confirming identity, purity, and concentration, and it's prescribed only after labs and a physician consultation